Health Care & Life Sciences » Biotechnology | Neptune Technologies & Bioressources Inc.

Neptune Technologies & Bioressources Inc. | Balance Sheet

Fiscal year is April-March. All values CAD Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
29,548.30
27,625.80
13,000.00
15,802.40
26,656.20
12,702.40
Total Accounts Receivable
18,970.90
8,743.10
10,864.30
13,699.40
5,640.40
5,806.40
Inventories
13,596.80
13,383.10
18,119.50
13,242.70
5,261.30
5,038.20
Other Current Assets
1,196.10
539.60
1,091.40
590.40
372.90
1,093.70
Total Current Assets
63,312.10
50,291.60
43,075.20
43,334.90
37,930.90
24,640.60
Net Property, Plant & Equipment
37,034.00
46,871.20
45,547.70
45,958.20
41,880.80
47,024
Total Investments and Advances
-
318.80
3,174.90
2,810.70
6,645.70
4,002.30
Long-Term Note Receivable
-
-
152.50
-
-
-
Intangible Assets
1,878.30
1,573.90
13,641.30
18,698.30
11,987.00
14,401.20
Other Assets
-
-
-
152.50
152.50
152.50
Total Assets
102,224.40
99,055.40
106,045.60
111,220.10
98,597.00
90,220.60
ST Debt & Current Portion LT Debt
18.00
540.00
7,527.40
7,192.30
4,661.40
Accounts Payable
9,474.90
4,523.50
5,650.00
4,344.60
2,425.60
Income Tax Payable
-
-
301.30
-
-
Other Current Liabilities
6,266.20
4,395.60
4,908.80
6,198.10
4,432.20
Total Current Liabilities
15,759.10
9,459.20
18,387.50
17,735.00
11,519.20
Long-Term Debt
10,081.20
14,006.80
20,154.00
17,145.60
-
Deferred Taxes
-
-
454.00
265.50
27.20
Other Liabilities
11,330.90
2,731.60
579.20
1,539.30
516.80
Total Liabilities
37,171.20
26,197.70
39,120.70
36,419.90
12,063.20
Common Equity (Total)
58,072.30
61,691.70
53,445.10
63,747.40
86,533.80
Total Shareholders' Equity
58,072.30
61,691.70
53,445.10
63,747.40
86,533.80
Total Equity
65,053.30
72,857.80
66,924.90
74,800.20
86,533.80
Liabilities & Shareholders' Equity
102,224.40
99,055.40
106,045.60
111,220.10
98,597.00
Accumulated Minority Interest
6,981.00
11,166.00
13,479.80
11,052.80
-

About Neptune Technologies & Bioressources

View Profile
Address
545, Promenade du Centropolis
Laval Québec H7T 0A3
Canada
Employees -
Website http://www.neptunecorp.com
Updated 07/08/2019
Neptune Technologies & Bioresources, Inc. engages in the development and commercialization specialty ingredients. It offers the MaxSimil a patented ingredient that may enhance the absorption of lipid-based nutraceuticals, and a variety of other marine and seed oils. It operates through the Nutraceutical, Cannabis, and Cardiovascular segments.